✦ LIBER ✦

Combined 5-fluorouracil and recombinant alpha-2A-interferon vs. 5-fluorouracil alone in metastatic colorectal carcinoma: A multicenter randomized study

✍ Scribed by Sergio Palmeri; Vittorio Gebbia

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 381 KB
Volume: 48
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.2930480528

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alpha-interferon in combination with 5-f

Alpha-interferon in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer: a phase I study

✍ C. J. A. Punt; P. H. M. Mulder; J. Th. M. Burghouts; D. J. Th. Wagener 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 331 KB

A Phase II trial of 5-fluorouracil and r

A Phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinoma

✍ Richard Pazdur; Jaffer A. Ajani; Rodger Winn; James Bearden; Robert J. Belt; Sus 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB 👁 3 views

A Phase I1 clinical trial of the combination of 5-fluorouracil (5-FU) and recombinant alpha-2a-interferon (a-2a-IFN) was conducted in 44 patients. Patients had not received chemotherapy previously and had measurable metastatic gastric carcinoma. 5-FU was administered as a continuous infusion at a do

A phase I trial of 5-fluorouracil, folin

A phase I trial of 5-fluorouracil, folinic acid, and alpha-2a-interferon in patients with metastatic colorectal carcinoma

✍ Ronald M. Bukowski; Go Inoshita; Prasad Yalavarthi; Siva Murthy; Vicki Gibson; G 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB 👁 2 views

Interferon alpha-2a and 5-fluorouracil f

Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma assessment of activity and toxicity

✍ Nancy Kemeny; Anas Younes; Karen Seiter; David Kelsen; Patricia Sammarco; Lynn A 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 621 KB

Continuous infusion of high-dose 5-fluor

Continuous infusion of high-dose 5-fluorouracil in combination with leucovorin and recombinant interferon-alpha-2b in patients with advanced colorectal cancer. A multicenter phase II study

✍ Cornelis J. A. Punt; Jos Th. M. Burghouts; Jelle J. Croles; Peter A. van Liessum 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views

Prospective randomized reappraisal of 5-

Prospective randomized reappraisal of 5-fluorouracil in metastatic colorectal carcinoma a comparative trial with 6-thioguanine

✍ Cary A. Presant; Alex E. Denes; Charlene Liu; Alfred A. Bartolucci; The Southeas 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB 👁 2 views

In order to redefine the effectiveness of 5-fluorouracil (5-FU) as palliative therapy in patients with metastatic colorectal carcinoma, and to compare the effectiveness of 6-thioguanine (6-TG) with that of 5-FU, we studied 176 patients with metastatic colorectal carcinoma in a randomized prospective